T7	Subject 27 35	patients
T8	Treatment 36 57	receiving anti-D IGIV
T9	Effect 118 191	hemoglobinemia, particularly disseminated intravascular coagulation (DIC)
T12	Drug 46 57	anti-D IGIV
T10	Speculation_cue 91 100	potential
T11	Adverse_event 101 114	complications
E1	Adverse_event:T11 
A1	Speculated E1